Vertex - Latest News [Page 1]

Medsafe Consents Trikafta

Thursday, 9 December 2021, 1:07 pm | Vertex

Vertex today announced it has gained consent from Medsafe for the use of Trikafta® (elexacaftor/tezacaftor/ ivacaftor and ivacaftor) for the treatment of cystic fibrosis (CF) in patients in New Zealand, ages six and over who have at least one F508del ... More >>

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL